Chemistry:Plozalizumab

From HandWiki
Short description: Monoclonal antibody
Plozalizumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
TargetCCR2
Clinical data
Other nameshu1D9
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6490H10052N1736O2018S42
Molar mass146032.46 g·mol−1

Plozalizumab (INN; hu1D9) is a humanized monoclonal antibody designed for the treatment of diabetic nephropathy and arteriovenous graft patency.[1][2]

This drug was developed by Takeda Pharmaceuticals International Co.

References